← Back to Discover
DIADEMA PARTNERS LP
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $791,347,834
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- VIKING THERAPEUTICS INC · COM · 92686J106 · shares · CALL: $47,623,408
- ABIVAX SA · SPONSORED ADS · 00370M103 · shares · CALL: $46,534,392
- BRISTOL-MYERS SQUIBB CO · COM · 110122108 · shares · CALL: $34,572,000
- ABIVAX SA · SPONSORED ADS · 00370M103 · shares · PUT: $33,634,824
- UNITED THERAPEUTICS CORP DEL · COM · 91307C102 · shares: $28,711,030
- REVOLUTION MEDICINES INC · COM · 76155X100 · shares: $26,072,747
- ABIVAX SA · SPONSORED ADS · 00370M103 · shares: $21,598,038
- COGENT BIOSCIENCES INC · COM · 19240Q201 · shares: $19,104,797
- BRISTOL-MYERS SQUIBB CO · COM · 110122108 · shares · PUT: $19,049,172
- BRIDGEBIO PHARMA INC · NOTE 1.750% 3/0 · 10806XAJ1 · principal: $18,620,000
Reported holdings
149 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| EQUILLIUM INC | COM | 29446K106 | — | 400,282 shares | $1,280,902 |
| PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | CALL | 388,200 shares | $1,168,482 |
| XERIS BIOPHARMA HOLDINGS INC | COM | 98422E103 | — | 132,746 shares | $1,051,348 |
| PHARVARIS N V | COM | N69605108 | — | 29,321 shares | $1,013,920 |
| HARMONY BIOSCIENCES HLDGS IN | COM | 413197104 | — | 26,864 shares | $978,118 |
| CARTESIAN THERAPEUTICS INC | COM NEW | 816212302 | — | 87,057 shares | $907,134 |
| AQUESTIVE THERAPEUTICS INC | COM | 03843E104 | CALL | 214,600 shares | $892,736 |
| RIGEL PHARMACEUTICALS INC | COM | 766559702 | — | 22,816 shares | $892,562 |
| SUMMIT THERAPEUTICS INC | COM | 86627T108 | — | 60,000 shares | $874,200 |
| PRECIGEN INC | COM | 74017N105 | — | 135,293 shares | $771,170 |
| DEFINIUM THERAPEUTICS INC | COM SHS | 24477V105 | — | 15,451 shares | $726,815 |
| PELTHOS THERAPEUTICS INC | COM SHS | 171126204 | — | 24,773 shares | $700,085 |
| PEPGEN INC | COM | 713317105 | — | 373,284 shares | $671,911 |
| CYBIN INC | COM NEW | 23256X407 | CALL | 100,000 shares | $661,000 |
| VOYAGER THERAPEUTICS INC | COM | 92915B106 | CALL | 150,000 shares | $525,000 |
| CG ONCOLOGY INC | COM | 156944100 | CALL | 7,300 shares | $518,665 |
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | — | 10,000 shares | $507,500 |
| CONNECT BIOPHARMA HLDGS LTD | SHS | G23549101 | — | 196,985 shares | $468,824 |
| LARIMAR THERAPEUTICS INC | COM | 517125100 | — | 146,637 shares | $447,243 |
| ELICIO THERAPEUTICS INC | COM | 28657F103 | CALL | 112,100 shares | $438,311 |
| ELICIO THERAPEUTICS INC | COM | 28657F103 | PUT | 100,000 shares | $391,000 |
| CELLECTAR BIOSCIENCES INC | COM NEW | 15117F880 | — | 138,341 shares | $384,588 |
| FOGHORN THERAPEUTICS INC | COM | 344174107 | — | 66,908 shares | $326,511 |
| AYTU BIOPHARMA INC | COM | 054754858 | — | 148,546 shares | $319,374 |
| OCUGEN INC | COM | 67577C105 | — | 200,000 shares | $306,000 |
| INOVIO PHARMACEUTICALS INC | COM SHS | 45773H409 | CALL | 275,200 shares | $302,720 |
| UROGEN PHARMA LTD | COM | M96088105 | — | 7,137 shares | $262,642 |
| AMGEN INC | COM | 031162100 | — | 102,701 shares | $214,645 |
| HERON THERAPEUTICS INC | COM | 427746102 | — | 458,723 shares | $195,783 |
| TALPHERA INC | COM NEW | 00444T209 | — | 153,563 shares | $158,170 |
| ANNEXON INC | COM | 03589W102 | — | 27,516 shares | $157,116 |
| MONOPAR THERAPEUTICS INC | COM NEW | 61023L207 | — | 1,630 shares | $150,922 |
| LAKELAND INDS INC | COM | 511795106 | — | 14,108 shares | $150,815 |
| UPSTREAM BIO INC | COM | 91678A107 | — | 19,093 shares | $132,124 |
| MEIRAGTX HLDGS PLC | COM | G59665102 | — | 8,368 shares | $113,052 |
| JATT II ACQUISITION CORP | ORD SHS | G50765109 | — | 9,021 shares | $102,479 |
| KAILERA THERAPEUTICS INC | COMMON STOCK | 482931102 | — | 3,621 shares | $79,771 |
| MANNKIND CORP | COM NEW | 56400P706 | — | 16,003 shares | $68,173 |
| ENTERA BIO LTD | SHS | M40527109 | — | 23,260 shares | $41,170 |
| ARS PHARMACEUTICALS INC | COM | 82835W108 | — | 4,860 shares | $38,929 |
| APREA THERAPEUTICS INC | COM NEW | 03836J201 | — | 44,907 shares | $36,029 |
| TVARDI THERAPEUTICS INC | COM | 140755307 | — | 16,607 shares | $31,553 |
| VISTAGEN THERAPEUTICS INC | COM | 92840H400 | CALL | 57,700 shares | $13,040 |
| NEXTCURE INC | COM NEW | 65343E207 | — | 7,742 shares | $12,387 |
| ATYR PHARMA INC | COM NEW | 002120202 | PUT | 12,500 shares | $7,460 |
| MEIRAGTX HLDGS PLC | COM | G59665102 | CALL | 500 shares | $6,755 |
| JADE BIOSCIENCES INC | COM NEW | 008064206 | PUT | 1,046 shares | $3,174 |
| ERASCA INC | COM | 29479A108 | CALL | 100 shares | $1,832 |
| CUE BIOPHARMA INC | COM | 22978P205 | CALL | 6 shares | $6 |